(Q46535889)

22 December 2017

title

Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure (English)

1 reference

22 December 2017

0 references

1 reference

3

1 reference

22 December 2017

Jens Tank

4

1 reference

22 December 2017

Friedrich C. Luft

5

1 reference

22 December 2017

Arya M Sharma

6

object named as

Arya M Sharma

1 reference

22 December 2017

Jens Jordan

7

object named as

Jens Jordan

1 reference

22 December 2017

Andreas Birkenfeld

1

object named as

Andreas L Birkenfeld

1 reference

22 December 2017

author name string

Christoph Schroeder

2

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

Clinical Autonomic Research

published in

1 reference

22 December 2017

volume

15

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

200-206

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s10286-005-0270-y

exact match

0 references

cites work

Sibutramine produces dose-related weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS10286-005-0270-Y

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-005-0270-Y

Cardiovascular neural regulation explored in the frequency domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-005-0270-Y

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-005-0270-Y

Heart rate variability: Standards of measurement, physiological interpretation, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-005-0270-Y

Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

21 January 2018

1 reference

12 December 2020

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

12 December 2020

Norepinephrine transporter function and autonomic control of metabolism

1 reference

12 December 2020

A new approach to analysis of the arterial baroreflex

1 reference

12 December 2020

Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle

1 reference

12 December 2020

The obesity epidemic is a worldwide phenomenon

1 reference

12 December 2020

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial

1 reference

12 December 2020

Adrenergic and reflex abnormalities in obesity-related hypertension

1 reference

12 December 2020

Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency

1 reference

12 December 2020

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

1 reference

12 December 2020

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

12 December 2020

Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collab

1 reference

12 December 2020

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients

1 reference

12 December 2020

The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females

1 reference

12 December 2020

Patterns of sympathetic neuron activity associated with Mayer waves

1 reference

12 December 2020

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991

1 reference

12 December 2020

Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition

1 reference

12 December 2020

Reference values of indices of spontaneous baroreceptor reflex sensitivity

1 reference

12 December 2020

Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans

1 reference

12 December 2020

Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study

1 reference

12 December 2020

Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance

1 reference

12 December 2020

Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model.

1 reference

12 December 2020

Sympathetic activation in obese normotensive subjects

1 reference

12 December 2020

Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits

1 reference

12 December 2020

The discovery and status of sibutramine as an anti-obesity drug

1 reference

12 December 2020

Paradoxical effect of sibutramine on autonomic cardiovascular regulation

1 reference

12 December 2020

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

1 reference

12 December 2020

10.1007/S10286-005-0270-Y

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017